Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicenter study. Italian Multicenter Slow Release Lanreotide Study Group.

PubWeight™: 1.96‹?› | Rank: Top 2%

🔗 View Article (PMID 8964833)

Published in J Clin Endocrinol Metab on June 01, 1996

Authors

M Giusti1, G Gussoni, C M Cuttica, G Giordano

Author Affiliations

1: DISEM, Cattedra di Endocrinologia, Genova, Italy.

Articles citing this

Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicentre study. J Clin Endocrinol Metab (1996) 1.41

Acromegaly. Endocrinol Metab Clin North Am (2008) 1.23

Somatostatin agonists for treatment of acromegaly. Mol Cell Endocrinol (2007) 0.92

Articles by these authors

(truncated to the top 100)

A novel sec-independent periplasmic protein translocation pathway in Escherichia coli. EMBO J (1998) 2.57

Gender differences and aging: effects on the human heart. J Am Coll Cardiol (1995) 2.49

Nitrate reductase of Escherichia coli: completion of the nucleotide sequence of the nar operon and reassessment of the role of the alpha and beta subunits in iron binding and electron transfer. Mol Gen Genet (1989) 1.90

Isolation and characterization of the nikR gene encoding a nickel-responsive regulator in Escherichia coli. J Bacteriol (1999) 1.88

Tellurite reductase activity of nitrate reductase is responsible for the basal resistance of Escherichia coli to tellurite. Microbiology (1997) 1.87

TMAO anaerobic respiration in Escherichia coli: involvement of the tor operon. Mol Microbiol (1994) 1.86

Asthma, allergy and respiratory infections: the vitamin D hypothesis. Allergy (2011) 1.50

A randomized study on eversion versus standard carotid endarterectomy: study design and preliminary results: the Everest Trial. J Vasc Surg (1998) 1.46

Retracted Exendin-4 reverts behavioural and neurochemical dysfunction in a pre-motor rodent model of Parkinson's disease with noradrenergic deficit. Br J Pharmacol (2012) 1.42

Clinical profile and predictors of in-hospital outcome in patients with heart failure: the FADOI "CONFINE" Study. Int J Cardiol (2011) 1.41

Serum leptin levels in males with delayed puberty during short-term pulsatile GnRH administration. J Endocrinol Invest (1999) 1.40

Pain management in internal medicine and effects of a standardised educational intervention: the FADOI-DOMINO study. Int J Clin Pract (2014) 1.40

Proposed nomenclature for the genes involved in molybdenum metabolism in Escherichia coli and Salmonella typhimurium. Mol Microbiol (1992) 1.40

No benefit from carotid intervention in fatal stroke prevention for >80-year-old patients. Eur J Vasc Endovasc Surg (2012) 1.39

Molecular genetic analysis of the moa operon of Escherichia coli K-12 required for molybdenum cofactor biosynthesis. Mol Microbiol (1993) 1.35

Involvement of the narJ and mob gene products in distinct steps in the biosynthesis of the molybdoenzyme nitrate reductase in Escherichia coli. Mol Microbiol (1996) 1.34

Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference. Acta Anaesthesiol Scand (2011) 1.31

TorD, a cytoplasmic chaperone that interacts with the unfolded trimethylamine N-oxide reductase enzyme (TorA) in Escherichia coli. J Biol Chem (1998) 1.30

Molecular analysis of the trimethylamine N-oxide (TMAO) reductase respiratory system from a Shewanella species. J Mol Biol (1998) 1.26

Intraoperative assessment of technical perfection in carotid endarterectomy: a prospective analysis of 1305 completion procedures. Collaborators of the EVEREST study group. Eversion versus standard carotid endartectomy. Eur J Vasc Endovasc Surg (1999) 1.15

NarJ is a specific chaperone required for molybdenum cofactor assembly in nitrate reductase A of Escherichia coli. Mol Microbiol (1998) 1.14

EPR and redox characterization of iron-sulfur centers in nitrate reductases A and Z from Escherichia coli. Evidence for a high-potential and a low-potential class and their relevance in the electron-transfer mechanism. Eur J Biochem (1992) 1.11

Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference. HSR Proc Intensive Care Cardiovasc Anesth (2011) 1.11

Expression and characterization of the Escherichia coli fdo locus and a possible physiological role for aerobic formate dehydrogenase. J Bacteriol (1995) 1.11

In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors. J Cell Physiol (1992) 1.08

The inducible trimethylamine N-oxide reductase of Escherichia coli K12: its localization and inducers. Biochim Biophys Acta (1989) 1.07

The inducible trimethylamine-N-oxide reductase of Escherichia coli K12: biochemical and immunological studies. Biochim Biophys Acta (1988) 1.07

Identification and expression of the Escherichia coli fdhD and fdhE genes, which are involved in the formation of respiratory formate dehydrogenase. J Bacteriol (1990) 1.06

Presence in the 'silent' terminus region of the Escherichia coli K12 chromosome of cryptic gene(s) encoding a new nitrate reductase. Mol Microbiol (1987) 1.04

Formation of active heterologous nitrate reductases between nitrate reductases A and Z of Escherichia coli. Mol Microbiol (1992) 1.04

Evidence for autocrine mitogenic stimulation by somatomedin-C/insulin-like growth factor I on an established human lung cancer cell line. Cancer Res (1988) 1.04

Biochemical and immunological evidence for a second nitrate reductase in Escherichia coli K12. Eur J Biochem (1987) 1.04

The coordination and function of the redox centres of the membrane-bound nitrate reductases. Cell Mol Life Sci (2001) 1.04

Purification and further characterization of the second nitrate reductase of Escherichia coli K12. Eur J Biochem (1990) 1.03

Involvement of the narJ or narW gene product in the formation of active nitrate reductase in Escherichia coli. Mol Microbiol (1992) 1.03

Complete coordination of the four Fe-S centers of the beta subunit from Escherichia coli nitrate reductase. Physiological, biochemical, and EPR characterization of site-directed mutants lacking the highest or lowest potential [4Fe-4S] clusters. Biochemistry (1996) 1.02

Mutants of Escherichia coli specifically deficient in respiratory formate dehydrogenase activity. J Gen Microbiol (1988) 1.01

Membrane reconstitution in chl-r mutants of Escherichia coli K 12. VIII. Purification and properties of the FA factor, the product of the chl B gene. Biochim Biophys Acta (1975) 1.01

Asthma severity in childhood and metabolomic profiling of breath condensate. Allergy (2012) 1.01

[Behavior of blood gastrin in humans after intravenous administration of cortisol]. Boll Soc Ital Biol Sper (1974) 1.00

Sudden and unexpected neonatal death: a protocol for the postmortem diagnosis of fatty acid oxidation disorders. Semin Perinatol (1999) 0.97

A common pathway for the activation of several molybdoenzymes in Escherichia coli K12. Biochim Biophys Acta (1984) 0.97

Crystal structure of oxidized trimethylamine N-oxide reductase from Shewanella massilia at 2.5 A resolution. J Mol Biol (1998) 0.97

Identification in various chlorate-resistant mutants of a protein involved in the activation of nitrate reductase in the soluble fraction of a chlA mutant of Escherichia coli K-12. Biochim Biophys Acta (1985) 0.97

Precursor forms of the subunits of nitrate reductase in chlA and chlB mutants of Escherichia coli K12. Eur J Biochem (1980) 0.97

Evidence for an increased somatomedin-C/insulin-like growth factor I content in primary human lung tumors. Cancer Res (1986) 0.96

3-Nitrotyrosine, a marker of nitrosative stress, is increased in breath condensate of allergic asthmatic children. Allergy (2006) 0.96

[A case of gossypiboma of the knee. Its computed tomographic diagnosis]. Radiol Med (2000) 0.96

Eversion versus conventional carotid endarterectomy: late results of a prospective multicenter randomized trial. J Vasc Surg (2000) 0.96

Comparison of target organ damage in renovascular and essential hypertension. Am J Hypertens (1996) 0.95

Requirement for phospholipids of the translocation of the trimethylamine N-oxide reductase through the Tat pathway in Escherichia coli. FEBS Lett (1999) 0.93

Serum leptin concentrations during the menstrual cycle in normal-weight women: effects of an oral triphasic estrogen-progestin medication. Eur J Endocrinol (2000) 0.93

Uterine smooth muscle tumor of uncertain malignant potential: a three-case report. Int J Gynecol Cancer (2007) 0.93

High substrate specificity and induction characteristics of trimethylamine-N-oxide reductase of Escherichia coli. Biochim Biophys Acta (1996) 0.93

Proliferation of T8-positive cytolytic T lymphocytes in response to thyroglobulin in human autoimmune thyroiditis: analysis of cell interactions and culture requirements. Clin Immunol Immunopathol (1985) 0.92

Conjunctival surface damage distribution in keratoconjunctivitis sicca. An impression cytology study. Ophthalmologica (1990) 0.92

Effect of epidermal growth factor on insulin-like growth factor-I (IGF-I) and IGF-binding protein synthesis by adult rat hepatocytes. Mol Cell Endocrinol (1992) 0.92

ST/G ACL reconstruction: double strand plus extra-articular sling vs double bundle, randomized study at 3-year follow-up. Scand J Med Sci Sports (2008) 0.92

Primary cutaneous plasmacytoma: a role for a triggering stimulus? Clin Exp Dermatol (2005) 0.91

Volume measurement with magnetic resonance imaging of hippocampus-amygdala formation in patients with anorexia nervosa. J Endocrinol Invest (2001) 0.91

Enzymatic and physiological properties of the tungsten-substituted molybdenum TMAO reductase from Escherichia coli. Mol Microbiol (1999) 0.89

Inhibition of tissue factor expression by hydroxyurea in polymorphonuclear leukocytes from patients with myeloproliferative disorders: a new effect for an old drug? J Thromb Haemost (2006) 0.89

Site-directed mutagenesis of conserved cysteine residues within the beta subunit of Escherichia coli nitrate reductase. Physiological, biochemical, and EPR characterization of the mutated enzymes. Biochemistry (1993) 0.89

Exogenous surfactant kinetics in infant respiratory distress syndrome: A novel method with stable isotopes. Am J Respir Crit Care Med (2000) 0.89

Molybdenum cofactor properties and [Fe-S] cluster coordination in Escherichia coli nitrate reductase A: investigation by site-directed mutagenesis of the conserved his-50 residue in the NarG subunit. Biochemistry (1998) 0.88

Oncocytic mucoepidermoid carcinoma of a submandibular gland: a case report and review of the literature. Int J Oral Maxillofac Surg (2007) 0.88

Dose-dependent suppression of serum prolactin by cabergoline in hyperprolactinaemia: a placebo controlled, double blind, multicentre study. European Multicentre Cabergoline Dose-finding Study Group. Clin Endocrinol (Oxf) (1992) 0.88

Circulating T lymphocytes in Hashimoto's disease: imbalance of subsets and presence of activated cells. Clin Immunol Immunopathol (1982) 0.88

Thyroid hormone stimulates the production of insulin-like growth factor I (IGF-I) by immature rat Sertoli cells. Mol Cell Endocrinol (1990) 0.88

Simultaneous measurement of the rates of appearance of palmitic and linoleic acid in critically ill infants. Pediatr Res (1997) 0.87

Hypopituitarism induced by traumatic brain injury in the transition phase. J Endocrinol Invest (2005) 0.87

Acrofacial dysostosis syndromes: a relevant prenatal dilemma. A case report and brief literature review. J Matern Fetal Neonatal Med (2007) 0.87

Identification and purification of a protein involved in the activation of nitrate reductase in the soluble fraction of a chlA mutant of Escherichia coli K12. Biochim Biophys Acta (1983) 0.87

A regulatory mutant of the trimethylamine N-oxide reductase of Escherichia coli K12. FEMS Microbiol Lett (1991) 0.87

[Effect of alendronate on periprosthetic bone loss after cemented primary total hip arthroplasty: a prospective randomized study]. Rev Chir Orthop Reparatrice Appar Mot (2003) 0.87

Long-term characterization, lagoon treatment and migration potential of landfill leachate: a case study in an active Italian landfill. Chemosphere (2004) 0.87

Thyroglobulin-induced T-cell in vitro proliferation in Hashimoto's thyroiditis: identification of the responsive subset and effect of monoclonal antibodies directed to Ia antigens. Clin Immunol Immunopathol (1984) 0.86

Coracoclavicular joints. Reflections upon incidence, pathophysiology and etiology of the different forms. Surg Radiol Anat (2003) 0.86

A genetic study of natural flor strains of Saccharomyces cerevisiae isolated during biological ageing from Sardinian wines. J Appl Microbiol (2000) 0.86

Spontaneous growth hormone and somatomedin-C/insulin-like growth factor-I secretion in obese subjects during puberty. J Endocrinol Invest (1988) 0.85

Symplastic leiomyoma of the scrotum. A case report. Pathologica (1996) 0.85

Prevention of venous thromboembolism in patients with advanced lung cancer receiving chemotherapy: a combined analysis of the PROTECHT and TOPIC-2 studies. J Thromb Haemost (2010) 0.85

Cerebrospinal fluid proteins in patients with leucoaraiosis: possible abnormalities in blood-brain barrier function. J Neurol Sci (1993) 0.85

Partial characterization of somatomedin C-like immunoreactivity secreted by breast cancer cells in vitro. Mol Cell Endocrinol (1987) 0.85

Endogenous surfactant metabolism in critically ill infants measured with stable isotope labeled fatty acids. Pediatr Res (1999) 0.85

A second phenazine methosulphate-linked formate dehydrogenase isoenzyme in Escherichia coli. Biochim Biophys Acta (1992) 0.85

The molybdenum cofactor of Escherichia coli nitrate reductase A (NarGHI). Effect of a mobAB mutation and interactions with [Fe-S] clusters. J Biol Chem (1998) 0.85

T lymphocyte subpopulations in Graves' disease: relationship with clinical conditions. Acta Endocrinol (Copenh) (1983) 0.84

In vivo and in vitro effect of growth hormone on estradiol secretion by human granulosa cells. J Clin Endocrinol Metab (1993) 0.84

A rare case of multiple congenital epulis. J Matern Fetal Neonatal Med (2004) 0.84

Uneventful pregnancy in an acromegalic patient treated with slow-release lanreotide: a case report. J Clin Endocrinol Metab (1999) 0.83

Hypopituitarism and growth hormone deficiency (GHD) after traumatic brain injury (TBI). Growth Horm IGF Res (2004) 0.83

Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue. J Clin Endocrinol Metab (1989) 0.83

Activation in vitro of respiratory nitrate reductase of Escherichia coli K12 grown in the presence of tungstate. Involvement of molybdenum cofactor. Eur J Biochem (1986) 0.83

Mitral valve prolapse in a case of Marfan syndrome with congenital cardiac disease, chronic obstructive pulmonary disease and schizophrenia. Pathologica (1995) 0.82

[Influence of platelet rich fibrin (PRF) on proliferation of human preadipocytes and tympanic keratinocytes: A new opportunity in facial lipostructure (Coleman's technique) and tympanoplasty?]. Rev Laryngol Otol Rhinol (Bord) (2007) 0.82

Escherichia coli molybdoenzymes can be activated by protein FA from several gram-negative bacteria. J Gen Microbiol (1989) 0.82

Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women. Am J Physiol (1999) 0.82

Removal of the high-potential [4Fe-4S] center of the beta-subunit from Escherichia coli nitrate reductase. Physiological, biochemical, and EPR characterization of site-directed mutated enzymes. Biochemistry (1993) 0.82

Biphasic effect of nitric oxide on testosterone and cyclic GMP production by purified rat Leydig cells cultured in vitro. Int J Androl (1999) 0.82